Basal, prandial, NPH, ultra-long, inhaled, 70/30, 75/25,

50/50, U-100, U-200, U-300, and U-500 insulin … the list of options for

patients with diabetes requiring insulin continues to expand. Current

guidelines for glycemic management of patients with type 2 diabetes provide

specific recommendations for the initiation of insulin therapy, but not insulin intensification. The recently published LanScape study provides a foundation for making evidence-based

clinical decisions.